Pregnane X-receptor promotes stem cell-mediated colon cancer relapse.
Identifieur interne : 001A32 ( PubMed/Corpus ); précédent : 001A31; suivant : 001A33Pregnane X-receptor promotes stem cell-mediated colon cancer relapse.
Auteurs : Chris Planque ; Fatemeh Rajabi ; Fanny Grillet ; Pascal Finetti ; François Bertucci ; Meritxell Gironella ; Juan José Lozano ; Bertrand Beucher ; Julie Giraud ; Véronique Garambois ; Charles Vincent ; Daniel Brown ; Ludovic Caillo ; Jovana Kantar ; André Pelegrin ; Michel Prudhomme ; Jérémie Ripoche ; Jean François Bourgaux ; Christophe Ginestier ; Antoni Castells ; Frédéric Hollande ; Julie Pannequin ; Jean Marc PascussiSource :
- Oncotarget [ 1949-2553 ] ; 2016.
Abstract
Colorectal cancer lethality usually results from post-treatment relapse in the majority of stage II-IV patients, due to the enhanced resistance of Cancer Stem Cells (CSCs). Here, we show that the nuclear receptor Pregnane X Receptor (PXR, NR1I2), behaves as a key driver of CSC-mediated tumor recurrence. First, PXR is specifically expressed in CSCs, where it drives the expression of genes involved in self-renewal and chemoresistance. Clinically, high levels of PXR correlate with poor recurrence-free survival in a cohort of >200 stage II/III colorectal cancer patients treated with chemotherapy, for whom finding biomarkers of treatment outcome is an urgent clinical need. shRNA silencing of PXR increased the chemo-sensitivity of human colon CSCs, reduced their self-renewal and tumor-initiating potential, and drastically delayed tumor recurrence in mice following chemotherapy. This study uncovers PXR as a key factor for CSC self-renewal and chemoresistance and targeting PXR thus represents a promising strategy to minimize colorectal cancer relapse by selectively sensitizing CSCs to chemotherapy.
DOI: 10.18632/oncotarget.10646
PubMed: 27448961
Links to Exploration step
pubmed:27448961Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pregnane X-receptor promotes stem cell-mediated colon cancer relapse.</title><author><name sortKey="Planque, Chris" sort="Planque, Chris" uniqKey="Planque C" first="Chris" last="Planque">Chris Planque</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Rajabi, Fatemeh" sort="Rajabi, Fatemeh" uniqKey="Rajabi F" first="Fatemeh" last="Rajabi">Fatemeh Rajabi</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Grillet, Fanny" sort="Grillet, Fanny" uniqKey="Grillet F" first="Fanny" last="Grillet">Fanny Grillet</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Finetti, Pascal" sort="Finetti, Pascal" uniqKey="Finetti P" first="Pascal" last="Finetti">Pascal Finetti</name><affiliation><nlm:affiliation>Centre de Recherche en Cancérologie de Marseille, INSERM UMR1068, CNRS UMR725, Marseille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Bertucci, Francois" sort="Bertucci, Francois" uniqKey="Bertucci F" first="François" last="Bertucci">François Bertucci</name><affiliation><nlm:affiliation>Centre de Recherche en Cancérologie de Marseille, INSERM UMR1068, CNRS UMR725, Marseille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Gironella, Meritxell" sort="Gironella, Meritxell" uniqKey="Gironella M" first="Meritxell" last="Gironella">Meritxell Gironella</name><affiliation><nlm:affiliation>Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigaciones Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Lozano, Juan Jose" sort="Lozano, Juan Jose" uniqKey="Lozano J" first="Juan José" last="Lozano">Juan José Lozano</name><affiliation><nlm:affiliation>Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigaciones Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Beucher, Bertrand" sort="Beucher, Bertrand" uniqKey="Beucher B" first="Bertrand" last="Beucher">Bertrand Beucher</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Giraud, Julie" sort="Giraud, Julie" uniqKey="Giraud J" first="Julie" last="Giraud">Julie Giraud</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Garambois, Veronique" sort="Garambois, Veronique" uniqKey="Garambois V" first="Véronique" last="Garambois">Véronique Garambois</name><affiliation><nlm:affiliation>Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vincent, Charles" sort="Vincent, Charles" uniqKey="Vincent C" first="Charles" last="Vincent">Charles Vincent</name><affiliation><nlm:affiliation>Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Brown, Daniel" sort="Brown, Daniel" uniqKey="Brown D" first="Daniel" last="Brown">Daniel Brown</name><affiliation><nlm:affiliation>Department of Pathology, University of Melbourne, Parkville, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Caillo, Ludovic" sort="Caillo, Ludovic" uniqKey="Caillo L" first="Ludovic" last="Caillo">Ludovic Caillo</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Kantar, Jovana" sort="Kantar, Jovana" uniqKey="Kantar J" first="Jovana" last="Kantar">Jovana Kantar</name><affiliation><nlm:affiliation>Laboratoire de Biochimie, CHU Carémeau, Nîmes, France.</nlm:affiliation></affiliation></author><author><name sortKey="Pelegrin, Andre" sort="Pelegrin, Andre" uniqKey="Pelegrin A" first="André" last="Pelegrin">André Pelegrin</name><affiliation><nlm:affiliation>Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Prudhomme, Michel" sort="Prudhomme, Michel" uniqKey="Prudhomme M" first="Michel" last="Prudhomme">Michel Prudhomme</name><affiliation><nlm:affiliation>Service de Chirurgie Digestive, CHU Carémeau, Nîmes, France.</nlm:affiliation></affiliation></author><author><name sortKey="Ripoche, Jeremie" sort="Ripoche, Jeremie" uniqKey="Ripoche J" first="Jérémie" last="Ripoche">Jérémie Ripoche</name><affiliation><nlm:affiliation>Service de Chirurgie Digestive, CHU Carémeau, Nîmes, France.</nlm:affiliation></affiliation></author><author><name sortKey="Bourgaux, Jean Francois" sort="Bourgaux, Jean Francois" uniqKey="Bourgaux J" first="Jean François" last="Bourgaux">Jean François Bourgaux</name><affiliation><nlm:affiliation>Service d'Hépato-Gastroentérologie, CHU Carémeau, Nîmes, France.</nlm:affiliation></affiliation></author><author><name sortKey="Ginestier, Christophe" sort="Ginestier, Christophe" uniqKey="Ginestier C" first="Christophe" last="Ginestier">Christophe Ginestier</name><affiliation><nlm:affiliation>Centre de Recherche en Cancérologie de Marseille, U1068 Inserm, Marseille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Castells, Antoni" sort="Castells, Antoni" uniqKey="Castells A" first="Antoni" last="Castells">Antoni Castells</name><affiliation><nlm:affiliation>Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigaciones Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Hollande, Frederic" sort="Hollande, Frederic" uniqKey="Hollande F" first="Frédéric" last="Hollande">Frédéric Hollande</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Pannequin, Julie" sort="Pannequin, Julie" uniqKey="Pannequin J" first="Julie" last="Pannequin">Julie Pannequin</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Pascussi, Jean Marc" sort="Pascussi, Jean Marc" uniqKey="Pascussi J" first="Jean Marc" last="Pascussi">Jean Marc Pascussi</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27448961</idno><idno type="pmid">27448961</idno><idno type="doi">10.18632/oncotarget.10646</idno><idno type="wicri:Area/PubMed/Corpus">001A32</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A32</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Pregnane X-receptor promotes stem cell-mediated colon cancer relapse.</title><author><name sortKey="Planque, Chris" sort="Planque, Chris" uniqKey="Planque C" first="Chris" last="Planque">Chris Planque</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Rajabi, Fatemeh" sort="Rajabi, Fatemeh" uniqKey="Rajabi F" first="Fatemeh" last="Rajabi">Fatemeh Rajabi</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Grillet, Fanny" sort="Grillet, Fanny" uniqKey="Grillet F" first="Fanny" last="Grillet">Fanny Grillet</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Finetti, Pascal" sort="Finetti, Pascal" uniqKey="Finetti P" first="Pascal" last="Finetti">Pascal Finetti</name><affiliation><nlm:affiliation>Centre de Recherche en Cancérologie de Marseille, INSERM UMR1068, CNRS UMR725, Marseille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Bertucci, Francois" sort="Bertucci, Francois" uniqKey="Bertucci F" first="François" last="Bertucci">François Bertucci</name><affiliation><nlm:affiliation>Centre de Recherche en Cancérologie de Marseille, INSERM UMR1068, CNRS UMR725, Marseille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Gironella, Meritxell" sort="Gironella, Meritxell" uniqKey="Gironella M" first="Meritxell" last="Gironella">Meritxell Gironella</name><affiliation><nlm:affiliation>Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigaciones Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Lozano, Juan Jose" sort="Lozano, Juan Jose" uniqKey="Lozano J" first="Juan José" last="Lozano">Juan José Lozano</name><affiliation><nlm:affiliation>Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigaciones Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Beucher, Bertrand" sort="Beucher, Bertrand" uniqKey="Beucher B" first="Bertrand" last="Beucher">Bertrand Beucher</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Giraud, Julie" sort="Giraud, Julie" uniqKey="Giraud J" first="Julie" last="Giraud">Julie Giraud</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Garambois, Veronique" sort="Garambois, Veronique" uniqKey="Garambois V" first="Véronique" last="Garambois">Véronique Garambois</name><affiliation><nlm:affiliation>Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vincent, Charles" sort="Vincent, Charles" uniqKey="Vincent C" first="Charles" last="Vincent">Charles Vincent</name><affiliation><nlm:affiliation>Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Brown, Daniel" sort="Brown, Daniel" uniqKey="Brown D" first="Daniel" last="Brown">Daniel Brown</name><affiliation><nlm:affiliation>Department of Pathology, University of Melbourne, Parkville, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Caillo, Ludovic" sort="Caillo, Ludovic" uniqKey="Caillo L" first="Ludovic" last="Caillo">Ludovic Caillo</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Kantar, Jovana" sort="Kantar, Jovana" uniqKey="Kantar J" first="Jovana" last="Kantar">Jovana Kantar</name><affiliation><nlm:affiliation>Laboratoire de Biochimie, CHU Carémeau, Nîmes, France.</nlm:affiliation></affiliation></author><author><name sortKey="Pelegrin, Andre" sort="Pelegrin, Andre" uniqKey="Pelegrin A" first="André" last="Pelegrin">André Pelegrin</name><affiliation><nlm:affiliation>Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Prudhomme, Michel" sort="Prudhomme, Michel" uniqKey="Prudhomme M" first="Michel" last="Prudhomme">Michel Prudhomme</name><affiliation><nlm:affiliation>Service de Chirurgie Digestive, CHU Carémeau, Nîmes, France.</nlm:affiliation></affiliation></author><author><name sortKey="Ripoche, Jeremie" sort="Ripoche, Jeremie" uniqKey="Ripoche J" first="Jérémie" last="Ripoche">Jérémie Ripoche</name><affiliation><nlm:affiliation>Service de Chirurgie Digestive, CHU Carémeau, Nîmes, France.</nlm:affiliation></affiliation></author><author><name sortKey="Bourgaux, Jean Francois" sort="Bourgaux, Jean Francois" uniqKey="Bourgaux J" first="Jean François" last="Bourgaux">Jean François Bourgaux</name><affiliation><nlm:affiliation>Service d'Hépato-Gastroentérologie, CHU Carémeau, Nîmes, France.</nlm:affiliation></affiliation></author><author><name sortKey="Ginestier, Christophe" sort="Ginestier, Christophe" uniqKey="Ginestier C" first="Christophe" last="Ginestier">Christophe Ginestier</name><affiliation><nlm:affiliation>Centre de Recherche en Cancérologie de Marseille, U1068 Inserm, Marseille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Castells, Antoni" sort="Castells, Antoni" uniqKey="Castells A" first="Antoni" last="Castells">Antoni Castells</name><affiliation><nlm:affiliation>Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigaciones Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Hollande, Frederic" sort="Hollande, Frederic" uniqKey="Hollande F" first="Frédéric" last="Hollande">Frédéric Hollande</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Pannequin, Julie" sort="Pannequin, Julie" uniqKey="Pannequin J" first="Julie" last="Pannequin">Julie Pannequin</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Pascussi, Jean Marc" sort="Pascussi, Jean Marc" uniqKey="Pascussi J" first="Jean Marc" last="Pascussi">Jean Marc Pascussi</name><affiliation><nlm:affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Oncotarget</title><idno type="eISSN">1949-2553</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Colorectal cancer lethality usually results from post-treatment relapse in the majority of stage II-IV patients, due to the enhanced resistance of Cancer Stem Cells (CSCs). Here, we show that the nuclear receptor Pregnane X Receptor (PXR, NR1I2), behaves as a key driver of CSC-mediated tumor recurrence. First, PXR is specifically expressed in CSCs, where it drives the expression of genes involved in self-renewal and chemoresistance. Clinically, high levels of PXR correlate with poor recurrence-free survival in a cohort of >200 stage II/III colorectal cancer patients treated with chemotherapy, for whom finding biomarkers of treatment outcome is an urgent clinical need. shRNA silencing of PXR increased the chemo-sensitivity of human colon CSCs, reduced their self-renewal and tumor-initiating potential, and drastically delayed tumor recurrence in mice following chemotherapy. This study uncovers PXR as a key factor for CSC self-renewal and chemoresistance and targeting PXR thus represents a promising strategy to minimize colorectal cancer relapse by selectively sensitizing CSCs to chemotherapy.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">27448961</PMID><DateCreated><Year>2016</Year><Month>07</Month><Day>24</Day></DateCreated><DateRevised><Year>2017</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>35</Issue><PubDate><Year>2016</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Pregnane X-receptor promotes stem cell-mediated colon cancer relapse.</ArticleTitle><Pagination><MedlinePgn>56558-56573</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.10646</ELocationID><Abstract><AbstractText>Colorectal cancer lethality usually results from post-treatment relapse in the majority of stage II-IV patients, due to the enhanced resistance of Cancer Stem Cells (CSCs). Here, we show that the nuclear receptor Pregnane X Receptor (PXR, NR1I2), behaves as a key driver of CSC-mediated tumor recurrence. First, PXR is specifically expressed in CSCs, where it drives the expression of genes involved in self-renewal and chemoresistance. Clinically, high levels of PXR correlate with poor recurrence-free survival in a cohort of >200 stage II/III colorectal cancer patients treated with chemotherapy, for whom finding biomarkers of treatment outcome is an urgent clinical need. shRNA silencing of PXR increased the chemo-sensitivity of human colon CSCs, reduced their self-renewal and tumor-initiating potential, and drastically delayed tumor recurrence in mice following chemotherapy. This study uncovers PXR as a key factor for CSC self-renewal and chemoresistance and targeting PXR thus represents a promising strategy to minimize colorectal cancer relapse by selectively sensitizing CSCs to chemotherapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Planque</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1191, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajabi</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1191, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grillet</LastName><ForeName>Fanny</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1191, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finetti</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre de Recherche en Cancérologie de Marseille, INSERM UMR1068, CNRS UMR725, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertucci</LastName><ForeName>François</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre de Recherche en Cancérologie de Marseille, INSERM UMR1068, CNRS UMR725, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gironella</LastName><ForeName>Meritxell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigaciones Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lozano</LastName><ForeName>Juan José</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigaciones Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beucher</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1191, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giraud</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1191, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garambois</LastName><ForeName>Véronique</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caillo</LastName><ForeName>Ludovic</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1191, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kantar</LastName><ForeName>Jovana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratoire de Biochimie, CHU Carémeau, Nîmes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelegrin</LastName><ForeName>André</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prudhomme</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service de Chirurgie Digestive, CHU Carémeau, Nîmes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ripoche</LastName><ForeName>Jérémie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Service de Chirurgie Digestive, CHU Carémeau, Nîmes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourgaux</LastName><ForeName>Jean François</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Service d'Hépato-Gastroentérologie, CHU Carémeau, Nîmes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ginestier</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre de Recherche en Cancérologie de Marseille, U1068 Inserm, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castells</LastName><ForeName>Antoni</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigaciones Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hollande</LastName><ForeName>Frédéric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1191, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Montpellier, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pannequin</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1191, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pascussi</LastName><ForeName>Jean Marc</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>CNRS UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1191, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2013 Feb;31(2):97-102</RefSource><PMID Version="1">23245395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 2012 Sep;61(9):1291-8</RefSource><PMID Version="1">21997556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Prev Res (Phila). 2013 Nov;6(11):1162-70</RefSource><PMID Version="1">24008128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2008 Jan;101(1):51-64</RefSource><PMID Version="1">17998271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer. 2010 Mar 02;9:46</RefSource><PMID Version="1">20196838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63</RefSource><PMID Version="1">17548814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Pharmacol. 2011 Dec 1;82(11):1771-80</RefSource><PMID Version="1">21920351</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Apr 15;69(8):3382-9</RefSource><PMID Version="1">19336570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2006 Mar;24(3):506-13</RefSource><PMID Version="1">16239320</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2012;916:373-85</RefSource><PMID Version="1">22914954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2008 Jun 18;3(6):e2428</RefSource><PMID Version="1">18560594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Pharm Des. 2012;18(19):2838-49</RefSource><PMID Version="1">22390767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Chemother Pharmacol. 2002 Apr;49(4):309-21</RefSource><PMID Version="1">11914911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Oct 15;69(20):8208-15</RefSource><PMID Version="1">19808966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 2007 Jan;71(1):220-9</RefSource><PMID Version="1">17028159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2009 Jun 2;100(11):1704-19</RefSource><PMID Version="1">19436303</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2007 Oct 11;1(4):389-402</RefSource><PMID Version="1">18371377</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(6):e20636</RefSource><PMID Version="1">21695188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Resist Updat. 2010 Feb-Apr;13(1-2):44-56</RefSource><PMID Version="1">20176501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Jun 15;70(12 ):5004-13</RefSource><PMID Version="1">20530687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Jul 12;277(28):25125-32</RefSource><PMID Version="1">11991950</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2009 Sep;27(9):2220-8</RefSource><PMID Version="1">19544409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2012 Dec;19(13):4193-201</RefSource><PMID Version="1">22878609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 2013 Jan 23;1491:1-13</RefSource><PMID Version="1">23123212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2007 Nov;1(5):555-67</RefSource><PMID Version="1">18371393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2009 Dec;16(12 ):3488-98</RefSource><PMID Version="1">19657699</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Dec;38(22):7943-63</RefSource><PMID Version="1">20693526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Lett. 2013 Apr;5(4):1093-1100</RefSource><PMID Version="1">23599746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2011 Aug;121(8):3220-32</RefSource><PMID Version="1">21747170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2012 Aug;11(8):1627-36</RefSource><PMID Version="1">22844074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2011 Feb 1;104(3):448-59</RefSource><PMID Version="1">21224854</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 1998 Sep 1;102(5):1016-23</RefSource><PMID Version="1">9727070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2013 Jan 1;328(1):1-9</RefSource><PMID Version="1">22939994</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2012 Sep;41(3):855-61</RefSource><PMID Version="1">22710732</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Feb;30(2):403-8</RefSource><PMID Version="1">20332446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2012 Mar;27(2):187-96</RefSource><PMID Version="1">22294766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2011 May 6;8(5):511-24</RefSource><PMID Version="1">21419747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Jun;30(6):2041-8</RefSource><PMID Version="1">20651349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2014 Dec;124(12):5453-65</RefSource><PMID Version="1">25384215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Mar 30;149(1):146-58</RefSource><PMID Version="1">22464327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Oct 1;69(19):7507-11</RefSource><PMID Version="1">19752085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2001 Mar 13;98 (6):3369-74</RefSource><PMID Version="1">11248085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 1;339(6119):543-8</RefSource><PMID Version="1">23239622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol Methods. 2009 Aug 15;347(1-2):70-8</RefSource><PMID Version="1">19567251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2009 Jul;137(1):15-7</RefSource><PMID Version="1">19450592</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 Jan 4;445(7123):111-5</RefSource><PMID Version="1">17122771</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2010 Dec;9(12):3186-99</RefSource><PMID Version="1">20889728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2013 Mar 1;132(5):1090-7</RefSource><PMID Version="1">22833293</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancers (Basel). 2011 Mar 22;3(1):1467-79</RefSource><PMID Version="1">24212669</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Mar 8;7(10):11018-32</RefSource><PMID Version="1">26783961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neoplasma. 2012;59(3):282-8</RefSource><PMID Version="1">22329848</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Oct 28;286(43):37813-29</RefSource><PMID Version="1">21878644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Proteomics. 2013 Oct 8;91:84-96</RefSource><PMID Version="1">23835434</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuro Oncol. 2012 Dec;14 (12 ):1452-64</RefSource><PMID Version="1">23132408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Res. 2011;19(12 ):555-61</RefSource><PMID Version="1">22812188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Disaster Med Public Health Prep. 2007 Jul;1(1):7-8</RefSource><PMID Version="1">18388587</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PXR</Keyword><Keyword MajorTopicYN="N">cancer stem cell</Keyword><Keyword MajorTopicYN="N">colorectal cancer</Keyword><Keyword MajorTopicYN="N">tumor recurrence</Keyword></KeywordList><CoiStatement>Authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>03</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>05</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27448961</ArticleId><ArticleId IdType="pii">10646</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.10646</ArticleId><ArticleId IdType="pmc">PMC5302934</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A32 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001A32 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:27448961
|texte= Pregnane X-receptor promotes stem cell-mediated colon cancer relapse.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27448961" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |